40
Participants
Start Date
October 9, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Timolol 0.5% eye drops and betamethasone valerate 0.1% cream
Topical timolol 0.5% eye drops (liquid form) twice daily with occlusion (i.e. covered with adhesive badge) and betamethasone valerate 0.1% cream twice daily with occlsuion for 1 month. For patients who do not have paronychia completely resolved after 4 weeks, the treatment assigned will be continued for another 4 to 8 weeks, up to 12 weeks to see the effect.
Betamethasone valerate 0.1% cream
The management according to routine clinical practice, including prescription of betamethasone valerate 0.1% cream twice daily for 1 month with occlusion. For patients who do not have paronychia completely resolved after 4 weeks, the treatment assigned will be continued for another 4 to 8 weeks, up to 12 weeks to see the effect.
RECRUITING
Queen Mary Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
OTHER